Here's what actually keeps a GLP-1 patient on program for 6 to 12 months: A structured check-in cadence, not "see you next month" Weigh-in and measurement touchpoints that create accountability between visits Automated encouragement timed to hit right before the typical plateau Proactive outreach before a patient's usual drop-off window, not after they've gone quiet Flexible, one-tap rebooking instead of a phone call nobody has time to make None of this is about better medicine
However, based on recent photos, the star has bypassed having an extreme Ozempic face (a telltale sign of too-quick weight loss associated with use of the drug, characterized by gauntness in the cheeks and eyes)
M., Rolny, I
GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro, Zepbound) are FDA-approved for type 2 diabetes and obesity management
While GLP-1 medications promote weight loss, they work best when paired with a balanced, healthy diet